"According to the latest study from BCC Research, the demand for Contract Research Organization (CRO) Services is expected to grow from $111.8 billion in 2024 to $166.0 billion by the end of 2029, at ...

A burgeoning number of studies are examining pediatric health equity, diversity, and inclusion (EDI). But if not done right, ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Affimed (AFMD – Research Report), retaining the price target ...

The "Synovial Sarcoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringA groundbreaking insight into the Synovial Sarcoma pipeline has been revealed for the year ...

Topics range from proton therapy and mobility rights to climate data for use in engineering / Approximately €82 million for first funding period ...

Activating certain neurons during fertile phases set off rejection behavior, while silencing them in non-receptive females ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.

A Lewis and Clark County District Court judge ruled to block a bill passed in 2023 by the Montana Legislature that would ...

is set to open on Dec. 10 and will further entrench the Alamo City as a leading center for innovative cancer care and ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research Report ... The company has shown consistent execution in its clinical programs, ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...